Clinical Trial of POD T 49P

Clinical Investigation of the Monofocal Toric IOL POD T 49P in Cataracteous Eyes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2052210134

Enrollment

Registered

2021-12-17

Start date

2021-12-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Perform cataract surgery and implant an intraocular lens

POD T 49P in the aphakic eye.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Subject with corneal astigmatism - Target postoperative refraction is emmetropia

Exclusion criteria

Exclusion criteria: - Subjects with diseases that affect postoperative visual acuity in the cornea or retina - Irregular corneal aberration - Poor mydriasis - Previous refractive surgery - Other protocol-defined exclusion criteria may apply.

Design outcomes

Primary

Measure	Time frame
Uncorrected visual acuity at Visit 4 Manifest Cylinder power at Visit 4	—

Contacts

Public ContactTsunemitsu Senta

BVI Japan

tsenta@bvimedical.com+81-3-5214-2277

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026